<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4085</journal-id>
<journal-title><![CDATA[Revista mexicana de urología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. urol.]]></abbrev-journal-title>
<issn>2007-4085</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Urología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-40852017000500389</article-id>
<article-id pub-id-type="doi">10.24245/revmexurol.v77i5.1111</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedad de Castleman unicéntrica renal]]></article-title>
<article-title xml:lang="en"><![CDATA[Renal unicentric Castleman&#8217;s disease]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez-Sánchez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Herrera-Muñoz]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Preciado-Estrella]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General Dr. Manuel Gea González División de Urología ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2017</year>
</pub-date>
<volume>77</volume>
<numero>5</numero>
<fpage>389</fpage>
<lpage>392</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-40852017000500389&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-40852017000500389&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-40852017000500389&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  ANTECEDENTES:  la enfermedad de Castleman describe un grupo de alteraciones linfoproliferativas causada por la producción excesiva de citosinas proinflamatorias, principalmente por interleucina-6 (IL-6). Los pacientes manifiestan signos y síntomas clínicos heterogéneos, con hallazgos histopatológicos de nódulos linfáticos y disfunción orgánica múltiple.  CASO CLÍNICO:  paciente masculino de 70 años de edad, con antecedente de diabetes tipo 2 e hipertensión arterial sistémica, diagnosticado de manera incidental con quiste renal izquierdo Bosniak I y masa en la región pélvica ipsilateral de 36 mm. El gamagrama renal reportó una tasa de filtrado glomerular de 22.5 mL/min en el riñón derecho y de 39.3 mL/min en el riñón izquierdo, por lo que se solicitó citología urinaria que resultó negativa. Los estudios de laboratorios reportaron: hemoglobina de 14.6 mg/dL, hematocrito 38%, leucocitos 7240, plaquetas 226000, TP 15.2, TTP 32 seg, glucosa 158 mg/dL y creatinina 0.7; el examen general de orina no mostró alteraciones. Se realizó nefrectomía radical sin registro de complicaciones tempranas o inmediatas, con adecuado control metabólico y hemodinámico, por lo que se otorgó el alta hospitalaria. El resultado histopatológico reportó tumor linfoplasmocitoide en el tejido adiposo del hilio renal (3.5 cm), compatible con enfermedad de Castleman.  CONCLUSIONES:  la enfermedad de Castleman es una alteración difícil de diagnosticar, por los que el estudio histopatológico es decisivo. Debido a su baja incidencia, aún no se establece el tratamiento adecuado; sin embargo, en las variantes unicéntricas la escisión quirúrgica es la única opción curativa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  BACKGROUND:  Castleman&#8217;s disease describes a group of lymphoproliferative disorders caused by excessive proinflammatory cytokine production, mainly of interleukin-6. Patients present with heterogeneous clinical features, with histopathologic lymph node changes, and often with multiple organ failure.  CLINICAL CASE:  A 70-year-old man had a past medical history of type 2 diabetes mellitus and high blood pressure. A left Bosniak I renal cyst and a 36-mm mass occupying the ipsilateral pelvic region were incidentally diagnosed. Kidney scintigram revealed a glomerular filtration rate of 22.5 mL/min in the right kidney and of 39.3 mL/ min in the left kidney. Complementary urinary cytology study was negative. Laboratory test results were: hemoglobin 14.6 mg/dL, hematocrit 38%, leukocytes 7240, platelets 226000, PT 15.2, PTT 32 sec, glucose 158 mg/dL, creatinine 0.7, and nonpathologic urinalysis. Radical nephrectomy was performed with no early or intermediate complications, metabolic control and hemodynamic control were adequate, and the patient was released. The histopathologic result was lymphoplasmacytic tumor in the adipose tissue of the renal hilum (3.5 cm) consistent with Castleman&#8217;s disease.  CONCLUSIONS:  Castleman&#8217;s disease is difficult to diagnose. Histopathologic study is essential, and given the low frequency of the disease, ideal management has not been established. However, surgical excision is the only curative option in its unicentric variants.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[enfermedad de Castleman]]></kwd>
<kwd lng="es"><![CDATA[enfermedades linfoproliferativas]]></kwd>
<kwd lng="es"><![CDATA[cáncer renal]]></kwd>
<kwd lng="en"><![CDATA[Castleman&#8217;s disease]]></kwd>
<kwd lng="en"><![CDATA[Lymphoproliferative disorders]]></kwd>
<kwd lng="en"><![CDATA[Kidney cancer]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castleman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Towne]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Case records of the Massachusetts General Hospital: Case no 40231]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1994</year>
<volume>250</volume>
<page-range>1001-5</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bowne]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lewin]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Filippa]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The management of unicentric and multicentric Castleman&#8217;s disease. A report of 16 cases and a review of the literature]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>1999</year>
<volume>85</volume>
<page-range>706-17</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keller]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Hochholzer]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Castleman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2002</year>
<volume>29</volume>
<page-range>670-83</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frizzera]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Bayrd]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systemic lympho-proliferative disorder with morphologic features of Castleman&#8217;s disease: clinical findings and clinicopathologic correlations in 15 patients]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>1985</year>
<volume>3</volume>
<page-range>1202-16</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Castleman&#8217;s disease. A Review]]></article-title>
<source><![CDATA[AIDS Rev]]></source>
<year>2009</year>
<volume>11</volume>
<page-range>3-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casper]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New approaches for the treatment of human herpes virus 8-associated disease]]></article-title>
<source><![CDATA[Rev Med Virol]]></source>
<year>2008</year>
<volume>18</volume>
<page-range>321-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Candelaria]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Luna-Ochoa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Labardini-Mendez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Virus y neoplasias hematolo&#769;gicas]]></article-title>
<source><![CDATA[Rev del Instituto Nacional de Cancerologi&#769;a]]></source>
<year>2009</year>
<volume>4</volume>
<page-range>217-35</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dham]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Castleman disease]]></article-title>
<source><![CDATA[Curr Opin Hematol]]></source>
<year>2007</year>
<volume>14</volume>
<page-range>354-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cronine]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Warneke]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Castleman &#769;s disease. An update on classification and the spectrum of associated lesions]]></article-title>
<source><![CDATA[Adv Anat Pathol]]></source>
<year>2009</year>
<volume>16</volume>
<page-range>236-46</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
